hamster |
LD50 |
subcutaneous |
113mg/kg (113mg/kg) |
|
British Journal of Cancer. Vol. 29, Pg. 359, 1974. |
hamster |
LDLo |
intravenous |
42mg/kg (42mg/kg) |
|
Journal of Pathology and Bacteriology. Vol. 92, Pg. 35, 1966. |
mammal (species unspecified) |
LD50 |
intravenous |
110mg/kg (110mg/kg) |
|
Gann Monograph on Cancer Research. Vol. 17, Pg. 107, 1975. |
mammal (species unspecified) |
LD50 |
oral |
110mg/kg (110mg/kg) |
|
Gann Monograph on Cancer Research. Vol. 17, Pg. 107, 1975. |
mouse |
LD50 |
intraperitoneal |
144mg/kg (144mg/kg) |
|
Cancer Research. Vol. 30, Pg. 11, 1970. |
rat |
LD50 |
intraperitoneal |
110mg/kg (110mg/kg) |
|
Nature. Vol. 222, Pg. 1064, 1969. |
rat |
LD50 |
intravenous |
108mg/kg (108mg/kg) |
|
Naunyn-Schmiedebergs Archiv fuer Pharmakologie und Experimentelle Pathologie. Vol. 257, Pg. 296, 1967. |
rat |
LD50 |
oral |
110mg/kg (110mg/kg) |
|
Zeitschrift fuer Krebsforschung. Vol. 69, Pg. 103, 1967. |
rat |
LDLo |
implant |
30mg/kg (30mg/kg) |
KIDNEY, URETER, AND BLADDER: OTHER CHANGES |
Chemico-Biological Interactions. Vol. 5, Pg. 139, 1972. |